Login / Signup

Assessing expectancy and suggestibility in a trial of escitalopram v. psilocybin for depression.

Balázs SzigetiBrandon WeissFernando E RosasDavid ErritzoeDavid NuttRobin Carhart-Harris
Published in: Psychological medicine (2024)
Overall, our results suggest that psychedelic therapy may be less vulnerable to expectancy biases than previously suspected. The relationship between baseline trait suggestibility and response to psilocybin therapy implies that highly suggestible individuals may be primed for response to this treatment.
Keyphrases
  • clinical trial
  • study protocol
  • major depressive disorder
  • genome wide
  • randomized controlled trial
  • phase iii
  • gene expression
  • mesenchymal stem cells
  • combination therapy
  • smoking cessation